Phase 2 Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a woman between 18 and 75 years old
- You have been diagnosed with ovarian cancer that has spread to the lining of the abdomen (peritoneum), confirmed by a tissue sample
- Your cancer has been classified as FIGO stage IIIB or IIIC (a specific staging system used for ovarian cancer — confirm with trial site if unsure of your stage)
- The cancer spread inside the abdomen can be seen directly (for example, during a procedure)
- The spread of cancer to the abdominal lining was identified before surgery using a scan such as an ultrasound, CT, MRI, or PET-CT
- You are able to follow the study procedures and are willing to sign a consent form agreeing to take part
Who may not be able to join:
- You are older than 75, have a very low ability to carry out daily activities, or are severely malnourished with a very low body weight (BMI of 16 or below)
- You have another serious illness that is currently getting worse or is not well controlled
- Your cancer has spread outside the abdomen, including to the lining around the lungs
- You have a type of ovarian cancer called mucinous carcinoma, or you have another active cancer (unless it has been in remission for more than 2 years)
- You have severe internal scarring in the abdomen (confirm with trial site)
- You are pregnant or currently breastfeeding
- You have tested positive for a BRCA1 or BRCA2 gene mutation
- You have certain conditions that would make a specific type of procedure used in this trial unsafe, such as a hole in the bowel, recent bowel surgery with reconnection, or repair of a bowel defect (confirm with trial site)
- You decide at any point during the study that you no longer wish to continue treatment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Alexey S. Dzasokhov, MD, PhD, Moscow Regional Oncological Dispensary
Phone: +79295596135
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Rate of complete surgical cytoreduction (CRS R0)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.